Page last updated: 2024-11-13
allatostatin protein, manduca sexta
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
allatostatin protein, Manduca sexta: inhibits juvenile hormone; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 44147062 |
| MeSH ID | M0194014 |
Synonyms (8)
| Synonym |
|---|
| pyroglutamyl-valyl-arginyl-phenylalanyl-arginyl-glutaminyl-cysteinyl-tyrosyl-phenylalanyl-asparaginyl-prolyl-isoleucyl-seryl-cysteinyl-phenylalanine |
| 137427-38-4 |
| allatostatin, manduca sexta |
| manduca sexta allatostatin |
| allatostatin protein, manduca sexta |
| 5-oxo-l-prolyl-l-valyl-l-arginyl-l-phenylalanyl-l-arginyl-l-glutaminyl-l-cysteinyl-l-tyrosyl-l-phenylalanyl-l-asparaginyl-l-prolyl-l-isoleucyl-l-seryl-l-cysteinyl-l-phenylalanine |
| l-phenylalanine, 5-oxo-l-prolyl-l-valyl-l-arginyl-l-phenylalanyl-l-arginyl-l-glutaminyl-l-cysteinyl-l-tyrosyl-l-phenylalanyl-l-asparaginyl-l-prolyl-l-isoleucyl-l-seryl-l-cysteinyl- |
| pglu-val-arg-phe-arg-gln-cys-tyr-phe-asn-pro-ile-ser-cys-phe-oh |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.39) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||